CRHBP
Basic information
Region (hg38): 5:76953045-76981158
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CRHBP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 12 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 0 | 2 |
Variants in CRHBP
This is a list of pathogenic ClinVar variants found in the CRHBP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-76953174-A-G | not specified | Uncertain significance (May 11, 2022) | ||
5-76953668-G-C | not specified | Uncertain significance (May 11, 2022) | ||
5-76953678-G-A | Benign (Aug 15, 2018) | |||
5-76954029-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
5-76954076-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
5-76954080-G-T | not specified | Uncertain significance (Feb 27, 2024) | ||
5-76954093-C-G | not specified | Uncertain significance (Apr 29, 2024) | ||
5-76954120-C-G | Benign (Aug 16, 2018) | |||
5-76954145-G-C | not specified | Uncertain significance (Oct 06, 2022) | ||
5-76955687-T-C | not specified | Uncertain significance (Dec 13, 2023) | ||
5-76958869-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
5-76963355-G-A | not specified | Uncertain significance (Dec 07, 2021) | ||
5-76963361-G-C | not specified | Uncertain significance (Mar 29, 2024) | ||
5-76963369-A-G | not specified | Uncertain significance (May 03, 2023) | ||
5-76968796-G-T | not specified | Uncertain significance (Jul 05, 2023) | ||
5-76968829-G-A | not specified | Uncertain significance (Dec 19, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CRHBP | protein_coding | protein_coding | ENST00000274368 | 7 | 28446 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.215 | 0.784 | 125741 | 0 | 7 | 125748 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.35 | 137 | 189 | 0.725 | 0.00000981 | 2111 |
Missense in Polyphen | 30 | 59.268 | 0.50618 | 661 | ||
Synonymous | 1.63 | 55 | 72.6 | 0.757 | 0.00000389 | 624 |
Loss of Function | 2.74 | 4 | 15.7 | 0.254 | 9.17e-7 | 163 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.000102 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000354 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000328 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds CRF and inactivates it. May prevent inappropriate pituitary-adrenal stimulation in pregnancy.;
- Pathway
- Corticotropin-releasing hormone signaling pathway;Signaling by GPCR;Signal Transduction;CRH;Class B/2 (Secretin family receptors);GPCR ligand binding
(Consensus)
Recessive Scores
- pRec
- 0.0999
Intolerance Scores
- loftool
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 46.49
Haploinsufficiency Scores
- pHI
- 0.680
- hipred
- Y
- hipred_score
- 0.806
- ghis
- 0.406
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.797
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Crhbp
- Phenotype
- growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- synaptic transmission, dopaminergic;maternal aggressive behavior;inflammatory response;signal transduction;female pregnancy;learning or memory;hormone-mediated signaling pathway;cellular response to drug;cellular response to potassium ion;hormone metabolic process;regulated exocytosis;behavioral response to ethanol;regulation of corticotropin secretion;negative regulation of corticotropin secretion;cellular response to calcium ion;cellular response to cocaine;cellular response to cAMP;cellular response to tumor necrosis factor;cellular response to estrogen stimulus;cellular response to estradiol stimulus;regulation of cellular response to stress;cellular response to gonadotropin-releasing hormone;negative regulation of corticotropin-releasing hormone receptor activity;regulation of NMDA receptor activity
- Cellular component
- extracellular region;extracellular space;nucleus;secondary lysosome;multivesicular body;endoplasmic reticulum;Golgi apparatus;microtubule;secretory granule;dendrite;dense core granule;varicosity;perikaryon;axon terminus
- Molecular function
- protein binding;peptide binding;corticotropin-releasing hormone binding